Word: fda
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Cheesebrough-Ponds was told to submit new data for the drug, Measurin, which it did. The FDA rejected the material, none of which was done by Cass Associates, because it "just didn't supply the necessary data," Dr. Robert J. Robinson, acting head of FDA's Bureau of Medicine, said yesterday...
...James L. Goddard, head of FDA, said last night that this was the first case he knows of where a drug was removed from the market because of faulty testing...
...eighty of the drugs tested by Cass have been under re-examination by the FDA, since they accused the private drug-testing firm this spring of "untrue statements of material fact" in 1963 tests of Norgesic, another pain-killer. The FDA charged that among those tested were a number of people who were dead at the time they were supposed to have taken Norgesic...
...will not accept any research done by Cass for any firm." Goddard said last night. In addition, the FDA has urged all drug manufacturers who have relied on Cass to submit new data from other drug-testing firms...
Officials of FDA would not say how many of the tests Cass Associates has done may have irregularities in them. Gifford D. Hampshire, of FDA's Information and Education Commission, said yesterday that there was no direct relationship between FDA's handling of the Norgesic case and the Measurin case, except that "once certain studies were suspect, we began to look into other drugs of Cass...